Skip to main content

Table 1 Clinicopathological characteristics of all patients (n = 48)

From: Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer

Characteristic

All patients

(n = 48)

Age (years)

66 ± 11

Gender (male/female)

32/16

WBC (/μL)

6747 ± 2794

TLC (/μL)

1627 ± 601

Alb (mg/dL)

3.8 ± 0.5

CRP (mg/dL)

0.65 ± 1.83

Tumor characteristic

 Differentiation (tub1/tub2/other)

27/19/2

 CEA (</≥ 5 ng/mL)

34/14

 CA19-9 (</≥ 37 IU/mL)

40/8

 Pre-CRT stage (I/II/II)

3/11/28

Treatment

 Chemotherapy (S-1/UFT/5-FU)

29/8/11

 Surgery (LAR/ISR/APR/local)

18/11/17/2

  1. WBC white blood cell, TLC total lymphocyte count, Alb albumin, CRP C-reactive protein, CEA carcinoembryonic antigen, tub1 well-differentiated tubular adenocarcinoma, tub2 moderately differentiated tubular adenocarcinoma, S-1 tegafur-gimeracil-oteracil, UFT tegafur-uracil, 5-FU 5-fluorouracil, CRT chemoradiotherapy, LAR low anterior resection, ISR intersphincteric resection, APR abdominoperineal resection